Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Apixaban (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- Acronyms CAP
- 07 Jun 2016 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
- 07 Jun 2016 Status changed from not yet recruiting to recruiting.
- 31 Oct 2015 New Source identified and integrated ( European ClinicalTrialsDatabase:EudraCT2014-005439-15 )